Eledon Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eledon Pharmaceuticals

12/08/2021 22:24

* Eledon Pharmaceuticals Inc  ELDN.OQ  reported a quarterly
adjusted loss of 50 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 57 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Eledon Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 50 cents​.
* The mean earnings estimate of analysts had fallen by
about 29.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Eledon Pharmaceuticals Inc shares had fallen by 18.2% this
quarter and lost 58.0% so far this year.
* The company reported a quarterly loss of $7.38 million.
* Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $32.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 09:24 p.m.  ​All
figures in US dollars unless otherwise stated